you right, that the grant was not significant factor for the stock price and other events, as you say, 'will light the fuse'...
We might see some news that will start moving stock up:
start of ALZ P2/3
start of Rhett P2
For the rocket to take off one of these events should happen:
results of BIIB testing and partnership
Partnership/licensing for ALZ with nice $$$ upfront and impassive royalty schedule
good trial results on all fronts.
When P2 Rhett starts and only 3 month to wait for the trial to complete. more time will be required to evaluate results but preliminary data analyses might be released, and if very good,
the rocket goes up.
As to BO, when AVXL shows excellent results for ALZ, even
5 Billion BO will not make sense for AVXL.
ALL just IMHO.